Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Common budgeting mistakes can quietly derail goals. Learn what they are and how to correct course with simple steps.
10,832 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
EURC’s record network growth has pushed on-chain activity to multi-year highs, underscoring a shift in Europe toward ...
Pediatrix (MD) 2025 earnings shaped a cautious optimism about growth and margins in a competitive pediatric care mark...
As American Express prepares to report earnings, the key question is how its card-fee growth stacks up against spendi...
When a single stock surges on earnings guidance, it signals more than a momentary spike. This guide explains why band...
CrowdStrike recently completed a stock split, sparking questions about its impact on liquidity and valuation. This gu...
Headline drama can ripple through your finances. Learn practical steps to stay focused, protect your investments, and...
Early retirees who keep working may see Social Security checks reduced by an annual earnings limit. This article expl...
What strategy (MSTR)? bitcoin has become a touchstone for corporate crypto bets. This article explains the concept, t...
Nvidia surged into the spotlight as a long-term wealth engine for many investors. This guide asks the hard question: ...
Bitcoin has seen shifts in on-chain dynamics that suggest selling pressure may be easing. Yet large holders continue ...
A new leadership style at the Fed could change how markets price future rate moves. This article breaks down the pote...